alzheimer-s

Documents about alzheimer-s

• Heterogenous microglial reactivity contrasts with stable vascular transcriptional programs in mouse models of Alzheimer's, CADASIL, and Traumatic Brain Injury.#380701NCBI PubMed Central
• A (19)F MRI/NIR-FL Nanoprobe for "Turn-On" Imaging of β-Secretase (BACE1) Activity in Alzheimer's Disease.#388668NCBI PubMed Central
• Associations of lifestyle factors and genetic risk with risk and rate advancement periods of dementia#397180OSF
• Streamlining eligibility assessment for Alzheimer's disease-modifying therapies: Prediction of MMSE scores using the digital clock and recall.#399714NCBI PubMed Central
• EEG biomarkers can predict early-stage Alzheimer's disease and correlate with intracerebral pathology: a multimodal machine learning study.#421239NCBI PubMed Central
• Development of a deep learning-based system for Alzheimer’s disease diagnosis#432260UTAR Institutional Repository
• Comment on "Executive and General Cognitive Domain as a Relevant Factor of Specific Neuropsychiatric Symptoms in Alzheimer's Disease".#446328NCBI PubMed Central
• Facial Emotion Recognition Deficits in Alzheimer's Disease Are Associated With Bilateral Uncinate Fasciculus Abnormalities and Frontotemporal-Limbic Microstructural Disorganisation.#449716NCBI PubMed Central
• Plasma p-tau as a biomarker for the differential diagnosis of Alzheimer's disease: a systematic review and meta-analysis.#449774NCBI PubMed Central
• TREM2 as a central immunometabolic hub in Alzheimer's disease: linking microglial states, lipid stress, and disease-stage-specific intervention.#457307NCBI PubMed Central
• Microglia-astrocyte crosstalk as a key organizing principle of Alzheimer's disease: from homeostatic cooperation to maladaptive signaling loops.#469249NCBI PubMed Central
• Integrated Virtual Screening and Molecular Electrostatic Surface Potential Descriptors for Predicting BACE1 Inhibitor Interactions in Alzheimer's Disease.#476846NCBI PubMed Central
• Double shrinkage transfer causal learning: An application to alzheimer’s disease#483569PLOS
• Meta analysis of glucose metabolism across Alzheimer’s, Parkinson’s and ALS Reveals emergence of adaptive brain glucometabolic responses and associated neurological functional profiles#164872Unpaywall
• A real-world feasibility study: at home longitudinal use of the Cumulus NeuLogiq® platform for electrophysiological and neurocognitive measures in patients with mild Alzheimer's Disease dementia.#360495NCBI PubMed Central
• Population-scale burden analysis of rare damaging coding variants identifies novel risk genes for Alzheimer's disease and related dementias and Parkinson's disease and related disorders#440255bioRxiv / medRxiv
• Machine-learning prediction and risk stratification of 12-month cognitive decline in Alzheimer's disease using routine clinical and MRI data.#13486NCBI PubMed Central
• Intraventricular hemorrhage, suspected EBV reactivation, and TBA-positive epilepsy after deep cervical lymphovenous anastomosis in Alzheimer’s disease: a case report.#15121NCBI PubMed Central
• Comparative effects of some pharmacological and non-pharmacological interventions on cognitive function in Alzheimer’s disease: A Bayesian network meta-analysis.#67528NCBI PubMed Central
• Depression modifies age-associated [(11)C]PiB-PET amyloid burden in a cohort enriched with risk for Alzheimer's disease.#125580NCBI PubMed Central
• Exome analysis of 22,319 individuals links extremely rare CNVs and 22q11.21 dosage to Alzheimer’s risk#132273Unpaywall
• The neural basis of prosocial effort-based decision making in older adults at risk for Alzheimer’s disease#135528Unpaywall
• Co-pathologies and biological processes beyond amyloid-beta and tau in people with Alzheimer's disease: Evidence from clinical cohort studies.#154197NCBI PubMed Central
• Plasma Aβ42/p-Tau217 ratio and p-Tau217 independently predict CSF-defined Alzheimer’s disease pathology in a Brazilian admixed cohort.#157097NCBI PubMed Central
• Recent Insights Into Alzheimer's Disease: Advances in Pathophysiology and Therapeutic Strategies#161229HAL (France)
• Natural Microbial Enrichment Modulates Microglial States and Transcriptional Programs Relevant to Alzheimer’s Disease#164892Unpaywall
• Streamlining Alzheimer's disease diagnosis: real-world validation of two-cut-off diagnostic models based on plasma p-tau/Aβ42 ratios.#170494NCBI PubMed Central
• Correspondence of Basal Forebrain Resting-State Functional Connectivity and Cerebral Glucose Metabolism Alterations With Neurotransmitter Maps in Alzheimer's Disease.#172103NCBI PubMed Central
• Value-based prices of emerging disease-modifying therapies for Alzheimer's disease in 174 countries: a cost-effectiveness and threshold analysis.#182283NCBI PubMed Central
• Remote, unsupervised assessment of cognitive impairment and decline in Alzheimer's disease using the Cogstate Brief Battery in ADNI-3.#193683NCBI PubMed Central
• Spearmint extract Neumentix downregulates amyloid-β accumulation by promoting phagocytosis in APP23 mice#194771OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Circulating Exosomes from Alzheimer's Disease Suppress Vascular Endothelial-Cadherin Expression and Induce Barrier Dysfunction in Recipient Brain Microvascular Endothelial Cell.#222871NCBI PubMed Central
• Synthesis, SAR, and multi-target evaluation of isonicotinoyl hydrazones as potent MPO/AChE inhibitors and metal chelators for Alzheimer's disease.#227717NCBI PubMed Central
• Association of Alzheimer's Disease and Related Dementias (ADRD) With Days at Home Among Medicare Beneficiaries After a Heart Failure Hospitalization.#247546NCBI PubMed Central
• Knowledge about Alzheimer's disease in medical, nursing, and psychology students in Ecuador: A problem that needs an urgent solution.#250937NCBI PubMed Central
• Association between obstructive sleep apnea severity and glymphatic-related DTI-ALPS alterations in newly diagnosed, Drug-Naïve Alzheimer's disease.#251157NCBI PubMed Central
• Adipokines at the Metabolic-Brain Interface : Therapeutic Modulation by Antidiabetic Agents and Natural Compounds in Alzheimer's Disease#270318Repositorio USS
• An interpretable deep learning diagnostic framework for early Alzheimer's disease based on EEG microstate spectra and multi-branch CNN.#275519NCBI PubMed Central
• Driving knowledge assessment in cognitively impaired older adults: evidence from geriatric day hospitals#280481HAL (France)
• Human iPSC-NSC-Derived Extracellular Vesicles Can Alleviate Alzheimer's Disease-Linked Impairments in Mitochondria, mTOR Signaling, Autophagy, and Hippocampal Neurogenesis.#288569NCBI PubMed Central
• Discovering non-linear dynamics of miRNAs in Alzheimer's disease-related cognitive impairment: a cross-species approach with explainable machine learning.#288621NCBI PubMed Central
• Radiomics-enhanced (18)F-AV45 PET/MRI for integrative assessment and centiloid estimation of amyloid-β burden in Alzheimer's disease.#297124NCBI PubMed Central
• Metabolic profile association with white matter hyperintensity in patients with mild cognitive impairment#311500Europe PMC
• The dangers of data double dipping in assessing the classification accuracies of blood biomarkers in Alzheimer's disease and related disorder research#321483bioRxiv / medRxiv
• Evaluation of CSF and plasma tau species as fluid surrogate candidates for tau PET in prodromal to moderate Alzheimer's disease.#326836NCBI PubMed Central
• Integrating home-based video teleneuropsychology into neurology clinical practice: Utility in patients with suspected typical or atypical Alzheimer's disease presentations.#327036NCBI PubMed Central
• Bacillus Calmette-Guérin (BCG) immunotherapy reprograms CNS immunity and alters Alzheimer's biomarkers: results from two open-label clinical trials.#340376NCBI PubMed Central
• Cross-sectional and longitudinal relationships among blood-brain barrier disruption, Alzheimer's disease biomarkers, and cognition in cognitively normal older adults.#345169NCBI PubMed Central
• The Vitamin D Receptor Ortholog Hr96 Modulates Neuronal and Mitochondrial Dynamics in a Drosophila Model of Alzheimer’s Disease#348715Repositorio USS
• Neurophysiological Differentiation of Conversion to Alzheimer's Disease: Longitudinal Changes in P300 Amplitude as an Indicator of Mild Cognitive Impairment Progression.#354770NCBI PubMed Central